• ViGeneron and WuXi Advanced Therapies Enter Partnership contractpharma
    December 03, 2020
    ​ViGeneron, a gene therapy company, and WuXi Advanced Therapies Inc. have announced a strategic partnership to accelerate production for the clinical development of VG901, a next-generation ophthalmic gene therapy program.
PharmaSources Customer Service